➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
McKesson
AstraZeneca
Express Scripts
Merck

Last Updated: October 25, 2020

DrugPatentWatch Database Preview

Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-06-03 1 THE PATENTS-IN-SUIT 17. United States Patent No. 6,774,122 (the “’122 patent”), entitled…to the expiration of AstraZeneca’s U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. … COUNT I: INFRINGEMENT OF U.S. PATENT NO. 6,774,122 31. Plaintiffs hereby reallege…INFRINGEMENT OF U.S. PATENT NO. 6,774,122 42. Plaintiffs hereby reallege…12. This is a civil action for patent infringement under the patent laws of the United States, Title External link to document
2016-03-30 194 ORDER, Covenant Not to Sue Regarding U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. Signed…2014 1 August 2016 1:14-cv-03547 830 Patent Defendant District Court, D. External link to document
2016-06-20 261 COUNT IX (U.S. Patent No. 6,774,122 Is Not Unenforceable) … Patent, the ’160 Patent, the ’680 Patent, and the ’139 Patent as the …Sagent’s counterclaims as to the ’160 patent because that patent is no longer alleged to be infringed …Sagent’s counterclaims as to the ’160 patent because that patent is no longer alleged to be infringed … ’122 patent, and that AstraZeneca UK Limited is the beneficial owner of the ’122 patent. AstraZeneca External link to document
2016-07-12 316 from infringing United States Patent Numbers 6,774,122, 7,456,160, 8,329,680 and 8,466,139, on…2014 1 August 2016 1:14-cv-03547 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Colorcon
McKinsey
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.